| Primary |
| Hypertension |
27.0% |
| Drug Use For Unknown Indication |
13.5% |
| Antiplatelet Therapy |
10.8% |
| Product Used For Unknown Indication |
8.1% |
| Stent Placement |
8.1% |
| Accidental Exposure |
4.1% |
| Blood Pressure Increased |
4.1% |
| Lung Neoplasm Malignant |
4.1% |
| Cerebral Infarction |
2.7% |
| Ischaemic Stroke |
2.7% |
| Thrombosis |
2.7% |
| Acute Coronary Syndrome |
1.4% |
| Angina Pectoris |
1.4% |
| Aortic Dissection |
1.4% |
| Arrhythmia |
1.4% |
| Arterial Stenosis |
1.4% |
| Asthma |
1.4% |
| Back Pain |
1.4% |
| Blood Pressure Inadequately Controlled |
1.4% |
| Cerebrovascular Accident |
1.4% |
|
| Anaemia |
9.7% |
| Renal Failure Acute |
9.7% |
| Transient Ischaemic Attack |
9.7% |
| Acute Myocardial Infarction |
6.5% |
| Dyspnoea |
6.5% |
| Hemiparesis |
6.5% |
| Hypertension |
6.5% |
| Thrombosis In Device |
6.5% |
| Adverse Drug Reaction |
3.2% |
| Angina Unstable |
3.2% |
| Aortic Dissection |
3.2% |
| Balance Disorder |
3.2% |
| Blood Pressure Increased |
3.2% |
| Bradycardia |
3.2% |
| Cardiac Disorder |
3.2% |
| Cardio-respiratory Arrest |
3.2% |
| Cold Sweat |
3.2% |
| Convulsion |
3.2% |
| Death |
3.2% |
| Diplopia |
3.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
24.3% |
| Hypertension |
22.4% |
| Product Used For Unknown Indication |
10.5% |
| Back Pain |
6.6% |
| Type 2 Diabetes Mellitus |
4.6% |
| Antiplatelet Therapy |
3.9% |
| Stent Placement |
3.9% |
| Anticoagulant Therapy |
2.6% |
| Essential Hypertension |
2.6% |
| Prostate Cancer |
2.6% |
| Aortic Dissection |
2.0% |
| Atrial Fibrillation |
2.0% |
| Blood Pressure |
2.0% |
| Depression |
2.0% |
| Coronary Artery Bypass |
1.3% |
| Coronary Artery Disease |
1.3% |
| Cough |
1.3% |
| Infection |
1.3% |
| Ischaemic Stroke |
1.3% |
| Multiple Sclerosis |
1.3% |
|
| Hypertension |
19.6% |
| Completed Suicide |
10.9% |
| Aortic Dissection |
6.5% |
| Poisoning |
6.5% |
| Thrombosis In Device |
6.5% |
| Agitation |
4.3% |
| Cardiac Disorder |
4.3% |
| Drug Ineffective |
4.3% |
| Drug Toxicity |
4.3% |
| Dyspnoea |
4.3% |
| Epistaxis |
4.3% |
| Pulmonary Congestion |
4.3% |
| Renal Failure |
4.3% |
| Agranulocytosis |
2.2% |
| Anaemia |
2.2% |
| Angina Unstable |
2.2% |
| Blood Pressure Inadequately Controlled |
2.2% |
| Blood Pressure Increased |
2.2% |
| Breast Cancer |
2.2% |
| Coronary Artery Occlusion |
2.2% |
|
| Concomitant |
| Hypertension |
24.9% |
| Product Used For Unknown Indication |
14.7% |
| Drug Use For Unknown Indication |
8.0% |
| Rheumatoid Arthritis |
8.0% |
| Pain |
5.9% |
| Diabetes Mellitus |
5.3% |
| Depression |
3.7% |
| Smoking Cessation Therapy |
3.3% |
| Blood Cholesterol Increased |
3.1% |
| Prophylaxis |
3.1% |
| Non-small Cell Lung Cancer |
2.9% |
| Back Pain |
2.2% |
| Asthma |
2.0% |
| Multiple Sclerosis |
2.0% |
| Rash |
2.0% |
| Ankylosing Spondylitis |
1.8% |
| Cardiac Disorder |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Tobacco User |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
|
| Drug Ineffective |
6.5% |
| Injection Site Pain |
6.5% |
| Nausea |
6.5% |
| Renal Failure Acute |
6.5% |
| Thrombocytopenia |
6.5% |
| Tremor |
6.5% |
| Vomiting |
6.5% |
| Alcohol Poisoning |
5.2% |
| Cerebrovascular Accident |
5.2% |
| Somnolence |
5.2% |
| Weight Decreased |
5.2% |
| Weight Increased |
5.2% |
| Abdominal Pain |
3.9% |
| Drug Effect Decreased |
3.9% |
| Hypophosphataemia |
3.9% |
| Myocardial Infarction |
3.9% |
| Non-small Cell Lung Cancer |
3.9% |
| Pericarditis |
3.9% |
| Aortic Aneurysm Rupture |
2.6% |
| Blood Glucose Increased |
2.6% |
|
| Interacting |
|
| Haemorrhage |
25.0% |
| Injection Site Haematoma |
25.0% |
| Melaena |
25.0% |
| Thrombotic Thrombocytopenic Purpura |
25.0% |
|
